Industry News
-
Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating2020-04-08The fist type III interferon in the world will intiating phase II trial in COVID-19
-
Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection2019-08-22PALO ALTO, Calif., August 20, 2019 — Eiger BioPharmaceuticals, Inc. , announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for peginterferon lambda (Lambda) for the treatment of HDV infection.
